CJC-1295 research guide

CJC-1295 in Shepit — GHRH Analog Research Guide

CJC-1295 research guide for Shepit. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.

Skip to Sourcing Guide Order CJC-1295 →

Shepit Guide to CJC-1295 Research

CJC-1295 isn't found on pharmacy shelves in Shepit or virtually any local market — this is a specialist compound available through a dedicated online market. The upside of this online-only market is that serious vendors differentiate entirely through their analytical documentation, giving researchers access to better quality signals than local retail ever could. What genuinely separates top CJC-1295 vendors is full COA coverage: HPLC for purity, mass spec for molecular identity verification, and endotoxin testing for safety screening. What follows is a vendor evaluation and quality guide built specifically around CJC-1295, covering everything a Shepit researcher needs to evaluate quality systematically.

Understanding CJC-1295 — Biology & Evidence

The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Shepit researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.

Buying CJC-1295: Quality Markers to Look For

The most consistent path to quality CJC-1295 is starting with community forums — peptide forums aggregate real purchasing experience that are more reliable than search results. A COA for CJC-1295 should include: HPLC purity percentage with the underlying chromatogram, mass spectrometry data establishing the correct molecular weight, endotoxin test results, and a residual solvent panel — all batch-matched. Negative indicators in CJC-1295 vendor evaluation: prices significantly below market average, vague sourcing information, no community presence, and COAs that lack endotoxin data. The lyophilised (freeze-dried) form of CJC-1295 is much more stable than liquid pre-made solutions — lyophilised powder maintains stability for years when frozen, while liquid preparations degrade within weeks even when refrigerated.

Order CJC-1295 — ships to Shepit
COA-verified · International tracking · Research grade
Order Now →

CJC-1295 Research Safety Guide

CJC-1295 operates outside approved pharmaceutical regulation — researchers should understand that the known safety profile is based on research literature rather than clinical trials. Temperature excursions — even brief warming above recommended storage temperature — can cause partial degradation without any obvious sign; always maintain cold chain and work with cold-shipped material. Verify the endotoxin level in your CJC-1295 batch COA before use in any in-vivo protocol — look for results reported in endotoxin units per mg or mL and confirm they fall within appropriate thresholds. For any individual considering CJC-1295 outside a formal research context: consult a qualified physician — this compound is not approved for human use and its risk profile is not equivalent to approved medications.

Frequently Asked Questions

What purity is required for CJC-1295 research?

CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.

What is CJC-1295?

CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.

Order CJC-1295 today
COA-verified · International shipping available
Order Now →